The outlook of companies tied to Viagra's past presents a intricate investment landscape. While the initial surge generated substantial profits , generic alternatives have significantly eroded market here share . Investing in associated pharmaceutical businesses now requires a thorough assessment of patent protection , evolving healthcare trends ,